BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• FDA

  Caliber Imaging & Diagnostics, Inc. Announces FDA 510(k) Clearance for its VIVASCOPE System

  The VIVASCOPE System is an industry-leading reflectance confocal microscopy device that allows dermatologists to non-invasively visualize cellular structures within the skin.

  May 15, 2018

   · 

  1 min read
• BioMidwest

  Medical Device Industry Survey Reveals Increase in Agile Development

  The survey results also show rising concerns about managing risk and proving compliance

  May 15, 2018

   · 

  2 min read
• Genetown

  PulsePoint Launches the First Centralized Data Activation and Measurement Technology Built Specifically for Health

  PulsePoint, today announced the launch of Genome by PulsePoint™

  May 15, 2018

   · 

  2 min read
• Business

  Anatara Announces Exclusive Global License Agreement with Zoetis

  Agreement represents the achievement of a major milestone for Anatara and its shareholders

  May 15, 2018

   · 

  2 min read
• Biotech Bay

  AllCells Announces New Faster Delivery Times

  New business model delivers fresh products in as little as three days.

  May 15, 2018

   · 

  2 min read
• Pharm Country

  New Drug-eluting Contact Lens to Provide Timed Drug Delivery Directly to Eye; Improving Recovery, Reducing Cost for Millions after Eye Surgery and LASIK

  Therapeutic soft lens designed to deliver pain and anti-infection drugs more evenly over time - replacing messy, less effective drops

  May 15, 2018

   · 

  3 min read
• Drug Development

  X4 Pharmaceuticals Presents Clinical Data Demonstrating Combinability of X4P-001-IO and Opdivo® (nivolumab) in Patients with Clear Cell Renal Cell Carcinoma

  X4 Pharmaceuticals, today announced results from a pilot study of X4P-001-IO in combination with Opdivo® (nivolumab) in patients with clear cell renal cell carcinoma (ccRCC).

  May 15, 2018

   · 

  3 min read
• Deals

  Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis

  Edico’s DRAGEN® Bio-IT Platform Delivers Faster, Streamlined Output for Next-Generation Sequencing

  May 15, 2018

   · 

  4 min read
• Business

  Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2018

  Product revenue for Q1 2018 was an increase of 142% compared to the same period last year.

  May 15, 2018

   · 

  2 min read
• BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence

  Financing included Norma Investments, OurCrowd.com, and Qure Ventures

  May 15, 2018

   · 

  3 min read